CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-25 | GUGGENHIME ANDREW President and CFO | Exercise or conversion · Stock Option (right to buy) | −17,052 | 476,566 | ||
| 2022-08-22 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $25.93 | $78K | 14,687 |
| 2022-08-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion | +3,100 | $5.35 | $17K | 45,287 |
| 2022-08-18 | GUGGENHIME ANDREW President and CFO | Sale | −2,551 | $25.13 | $64K | 42,736 |
| 2022-08-18 | GUGGENHIME ANDREW President and CFO | Sale | −549 | $25.89 | $14K | 42,187 |
| 2022-08-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion · Stock Option (right to buy) | −3,100 | 493,618 | ||
| 2022-08-17 | Wassil Jim Chief Operating Officer | Exercise or conversion | +2,800 | $2.42 | $7K | 47,306 |
| 2022-08-17 | Wassil Jim Chief Operating Officer | Sale | −2,800 | $25.15 | $70K | 44,506 |
| 2022-08-17 | Wassil Jim Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −2,800 | 227,526 | ||
| 2022-08-15 | PICKERING GRANT Chief Executive Officer | Sale | −10,392 | $25.54 | $265K | 673,064 |
| 2022-08-15 | PICKERING GRANT Chief Executive Officer | Sale | −608 | $26.30 | $16K | 672,456 |
| 2022-08-05 | Fairman Jeff VP, Research | Sale | −5,000 | $25.70 | $129K | 306,227 |
| 2022-08-04 | Fairman Jeff VP, Research | Sale | −10,000 | $25.50 | $255K | 311,227 |
| 2022-07-27 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $25.00 | $75K | 17,687 |
| 2022-07-26 | PICKERING GRANT Chief Executive Officer | Sale | −5,000 | $23.26 | $116K | 167,830 |
| 2022-07-26 | PICKERING GRANT Chief Executive Officer | Sale | −5,000 | $23.27 | $116K | 167,830 |
| 2022-07-20 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $25.00 | $75K | 20,687 |
| 2022-07-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion | +3,100 | $5.35 | $17K | 45,287 |
| 2022-07-18 | GUGGENHIME ANDREW President and CFO | Sale | −3,091 | $24.53 | $76K | 42,196 |
| 2022-07-18 | GUGGENHIME ANDREW President and CFO | Sale | −9 | $25.00 | $225 | 42,187 |
Page 46 of 51 · 1,004 trades